| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |